CITADEL ADVISORS LLC historic quarter change: Foreign ADRs, Sold out
In depositary receipts for foreign shares (depositary receipts and foreign shares traded over the counter), over 51 quarters from 2013-06-30 to 2026-03-31, CITADEL ADVISORS LLC opened 793 positions, added to 554, reduced 514 and sold out of 741.
- Q3 2022: Stock GSK PLC; Country of operation —; Class SPONSORED ADR; Shares before 1,339,209.
- Q3 2022: Stock NATWEST GROUP PLC; Country of operation —; Class SPONS ADR 2 ORD; Shares before 875,929.
- Q3 2022: Stock COMPANHIA BRASILEIRA DE DIST; Country of operation —; Class SPONSORED ADR; Shares before 1,065,594.
- Q3 2022: Stock AMERICA MOVIL SAB DE CV; Country of operation —; Class SPON ADR L SHS; Shares before 123,201.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1423053), 51 quarters: Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q4 2023 (2023-09-30 to 2023-12-31, filed 2024-02-14); Q3 2023 (2023-06-30 to 2023-09-30, filed 2023-11-14); Q2 2023 (2023-03-31 to 2023-06-30, filed 2023-08-14); Q1 2023 (2022-12-31 to 2023-03-31, filed 2023-05-15); Q4 2022 (2022-09-30 to 2022-12-31, filed 2023-02-14); Q3 2022 (2022-06-30 to 2022-09-30, filed 2022-11-14); Q2 2022 (2022-03-31 to 2022-06-30, filed 2022-08-15); Q1 2022 (2021-12-31 to 2022-03-31, filed 2022-05-16); Q4 2021 (2021-09-30 to 2021-12-31, filed 2022-02-14); Q3 2021 (2021-06-30 to 2021-09-30, filed 2021-11-15); Q2 2021 (2021-03-31 to 2021-06-30, filed 2021-08-16); Q1 2021 (2020-12-31 to 2021-03-31, filed 2021-05-17); Q4 2020 (2020-09-30 to 2020-12-31, filed 2021-02-16); Q3 2020 (2020-06-30 to 2020-09-30, filed 2020-11-16); Q2 2020 (2020-03-31 to 2020-06-30, filed 2020-08-14); Q1 2020 (2019-12-31 to 2020-03-31, filed 2020-05-15); Q4 2019 (2019-09-30 to 2019-12-31, filed 2020-02-14); Q3 2019 (2019-06-30 to 2019-09-30, filed 2019-11-14); Q2 2019 (2019-03-31 to 2019-06-30, filed 2019-08-14); Q1 2019 (2018-12-31 to 2019-03-31, filed 2019-05-15); Q4 2018 (2018-09-30 to 2018-12-31, filed 2019-02-14); Q3 2018 (2018-06-30 to 2018-09-30, filed 2018-11-13); Q2 2018 (2018-03-31 to 2018-06-30, filed 2018-08-10); Q1 2018 (2017-12-31 to 2018-03-31, filed 2018-05-11); Q4 2017 (2017-09-30 to 2017-12-31, filed 2018-02-09); Q3 2017 (2017-06-30 to 2017-09-30, filed 2017-11-09); Q2 2017 (2017-03-31 to 2017-06-30, filed 2017-08-11); Q1 2017 (2016-12-31 to 2017-03-31, filed 2017-05-12); Q4 2016 (2016-09-30 to 2016-12-31, filed 2017-02-10); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2009-12-31.
| Quarter | Stock | Country of operation | Class | Shares before | Shares after | Share change | Value before | Value after | Value change | Filed |
|---|
| Q3 2022 | GSK PLC
CUSIP 37733W105 | — | SPONSORED ADR | 1,339,209 | 0 | -1,339,209 | $58,295 | $0 | -$58,295 | 2022-11-14 |
|---|
| Q3 2022 | NATWEST GROUP PLC
CUSIP 639057108 | — | SPONS ADR 2 ORD | 875,929 | 0 | -875,929 | $4,773 | $0 | -$4,773 | 2022-11-14 |
|---|
| Q3 2022 | COMPANHIA BRASILEIRA DE DIST
CUSIP 20440T300 | — | SPONSORED ADR | 1,065,594 | 0 | -1,065,594 | $3,303 | $0 | -$3,303 | 2022-11-14 |
|---|
| Q3 2022 | AMERICA MOVIL SAB DE CV
CUSIP 02364W105 | — | SPON ADR L SHS | 123,201 | 0 | -123,201 | $2,517 | $0 | -$2,517 | 2022-11-14 |
|---|
| Q3 2022 | NATURA &CO HLDG S A
CUSIP 63884N108 | — | ADS | 266,625 | 0 | -266,625 | $1,389 | $0 | -$1,389 | 2022-11-14 |
|---|
| Q3 2022 | CHINA LIFE INS CO LTD
CUSIP 16939P106 | — | SPON ADR REP H | 133,351 | 0 | -133,351 | $1,152 | $0 | -$1,152 | 2022-11-14 |
|---|
| Q3 2022 | MICRO FOCUS INTL PLC
CUSIP 594837403 | — | SPON ADR NEW | 292,052 | 0 | -292,052 | $984 | $0 | -$984 | 2022-11-14 |
|---|
| Q3 2022 | INDUSTRIAS BACHOCO SAB
CUSIP 456463108 | — | SPON ADR B | 9,455 | 0 | -9,455 | $410 | $0 | -$410 | 2022-11-14 |
|---|
| Q3 2022 | CONNECT BIOPHARMA HLDGS LTD
CUSIP 207523101 | — | ADS | 409,659 | 0 | -409,659 | $357 | $0 | -$357 | 2022-11-14 |
|---|
| Q3 2022 | MOBILE TELESYSTEMS PUB JT ST
CUSIP 607409109 | — | SPONSORED ADR | 581,178 | 0 | -581,178 | $286 | $0 | -$286 | 2022-11-14 |
|---|
| Q3 2022 | NAAS TECHNOLOGY INC
CUSIP 62955X102 | — | SPONSORED ADS | 41,134 | 0 | -41,134 | $246 | $0 | -$246 | 2022-11-14 |
|---|
| Q3 2022 | ALUMINUM CORP CHINA LIMITED
CUSIP 022276109 | — | SPON ADR H SHS | 19,709 | 0 | -19,709 | $187 | $0 | -$187 | 2022-11-14 |
|---|
| Q3 2022 | GENETRON HLDGS LTD
CUSIP 37186H100 | — | ADS | 63,341 | 0 | -63,341 | $108 | $0 | -$108 | 2022-11-14 |
|---|
| Q3 2022 | 111 INC
CUSIP 68247Q102 | — | ADS | 52,062 | 0 | -52,062 | $107 | $0 | -$107 | 2022-11-14 |
|---|
| Q3 2022 | KAZIA THERAPEUTICS LTD
CUSIP 48669G105 | — | SPONSORED ADR | 22,769 | 0 | -22,769 | $95 | $0 | -$95 | 2022-11-14 |
|---|
| Q3 2022 | FANHUA INC
CUSIP 30712A103 | — | SPONSORED ADR | 15,432 | 0 | -15,432 | $80 | $0 | -$80 | 2022-11-14 |
|---|
| Q3 2022 | ACHILLES THERAPEUTICS PLC
CUSIP 00449L102 | — | SPONSORED ADS | 27,468 | 0 | -27,468 | $69 | $0 | -$69 | 2022-11-14 |
|---|
| Q3 2022 | VIOMI TECHNOLOGY CO LTD
CUSIP 92762J103 | Cayman Islands | SPONSORED ADS | 33,341 | 0 | -33,341 | $57 | $0 | -$57 | 2022-11-14 |
|---|
| Q3 2022 | OKYO PHARMA LTD
CUSIP 679345108 | — | SPONSORED ADS | 26,864 | 0 | -26,864 | $54 | $0 | -$54 | 2022-11-14 |
|---|
| Q3 2022 | KUKE MUSIC HLDG LTD
CUSIP 501229108 | — | SPONSORED ADS | 29,141 | 0 | -29,141 | $52 | $0 | -$52 | 2022-11-14 |
|---|
| Q3 2022 | 4D PHARMA PLC
CUSIP 35085K109 | — | SPONSORED ADS | 28,166 | 0 | -28,166 | $46 | $0 | -$46 | 2022-11-14 |
|---|
| Q3 2022 | YUNJI INC
CUSIP 98873N107 | — | ADS RP CL A | 39,956 | 0 | -39,956 | $42 | $0 | -$42 | 2022-11-14 |
|---|
| Q3 2022 | GENETIC TECHNOLOGIES LTD
CUSIP 37185R307 | — | NEW SPONSRD ADR | 36,117 | 0 | -36,117 | $41 | $0 | -$41 | 2022-11-14 |
|---|
| Q3 2022 | SOS LIMITED
CUSIP 83587W106 | — | SPNSORD ADS NEW | 200,175 | 0 | -200,175 | $38 | $0 | -$38 | 2022-11-14 |
|---|
| Q3 2022 | STEALTH BIOTHERAPEUTICS CORP
CUSIP 85789A105 | — | SPONSORED ADS | 141,226 | 0 | -141,226 | $36 | $0 | -$36 | 2022-11-14 |
|---|
| Q3 2022 | TUNIU CORP
CUSIP 89977P106 | — | SPONSORED ADS A | 32,026 | 0 | -32,026 | $34 | $0 | -$34 | 2022-11-14 |
|---|
| Q3 2022 | Q&K INTL GROUP LTD
CUSIP 74738J201 | — | SPONSRED ADS NEW | 15,093 | 0 | -15,093 | $29 | $0 | -$29 | 2022-11-14 |
|---|
| Q3 2022 | BIOLINERX LTD
CUSIP 09071M205 | — | SPONSORED ADS | 22,774 | 0 | -22,774 | $29 | $0 | -$29 | 2022-11-14 |
|---|
| Q3 2022 | PURPLE BIOTECH LTD
CUSIP 74638P109 | — | SPONSORED ADS | 11,904 | 0 | -11,904 | $28 | $0 | -$28 | 2022-11-14 |
|---|
| Q3 2022 | BIONDVAX PHARMACEUTICALS LTD
CUSIP 09073Q105 | — | SPOND ADS | 23,844 | 0 | -23,844 | $28 | $0 | -$28 | 2022-11-14 |
|---|
| Q3 2022 | QUTOUTIAO INC
CUSIP 74915J206 | — | ADS REP SHS A | 23,467 | 0 | -23,467 | $23 | $0 | -$23 | 2022-11-14 |
|---|
| Q3 2022 | GRUPO SUPERVIELLE S.A.
CUSIP 40054A108 | Argentina | SPONSORED ADR | 15,945 | 0 | -15,945 | $22 | $0 | -$22 | 2022-11-14 |
|---|
| Q3 2022 | AIRNET TECHNOLOGY INC
CUSIP 00941Q104 | — | SPONSORED ADS | 13,622 | 0 | -13,622 | $21 | $0 | -$21 | 2022-11-14 |
|---|
| Q3 2022 | LIXIANG ED HLDG CO LTD
CUSIP 53934A115 | — | ADS | 10,120 | 0 | -10,120 | $20 | $0 | -$20 | 2022-11-14 |
|---|
| Q3 2022 | GETNET ADQUIRENCIA E SERVICO
CUSIP 37428A103 | — | SPONSORED ADS | 11,349 | 0 | -11,349 | $18 | $0 | -$18 | 2022-11-14 |
|---|
| Q3 2022 | 36KR HOLDINGS INC
CUSIP 88429K103 | — | SPONSORED ADS | 14,871 | 0 | -14,871 | $15 | $0 | -$15 | 2022-11-14 |
|---|
| Q3 2022 | MOLECULAR DATA INC
CUSIP 60852L205 | — | SPONSORD ADS NEW | 27,603 | 0 | -27,603 | $15 | $0 | -$15 | 2022-11-14 |
|---|
| Q3 2022 | AKARI THERAPEUTICS PLC
CUSIP 00972G108 | — | SPONSORED ADR | 15,064 | 0 | -15,064 | $15 | $0 | -$15 | 2022-11-14 |
|---|
| Q3 2022 | ORCHARD THERAPEUTICS PLC
CUSIP 68570P101 | — | ADS | 21,409 | 0 | -21,409 | $13 | $0 | -$13 | 2022-11-14 |
|---|
| Q3 2022 | SECOO HLDG LTD
CUSIP 81367P101 | — | SPONSORED ADR | 54,400 | 0 | -54,400 | $12 | $0 | -$12 | 2022-11-14 |
|---|
| Q3 2022 | LIZHI INC
CUSIP 53933L104 | — | ADS | 10,180 | 0 | -10,180 | $12 | $0 | -$12 | 2022-11-14 |
|---|
| Q3 2022 | QUOIN PHARMACEUTICALS LTD
CUSIP 74907L102 | — | SPON ADS NEW 21 | 19,582 | 0 | -19,582 | $9 | $0 | -$9 | 2022-11-14 |
|---|
| Q3 2022 | ECMOHO LTD
CUSIP 27888P104 | — | SPONSORED ADS | 53,084 | 0 | -53,084 | $9 | $0 | -$9 | 2022-11-14 |
|---|
| Q3 2022 | VEON LTD
CUSIP 91822M106 | — | SPONSORED ADR | 15,346 | 0 | -15,346 | $6 | $0 | -$6 | 2022-11-14 |
|---|